What is Insulin
A note on use: The peptides and compounds referenced in this article are not FDA-approved for human use. This content is intended for research and educational purposes only and is not intended as medical guidance or encouragement for individual use.
What is Insulin? (Reviewed and updated: June 2026)

Insulin is one of the most important hormones in the human body. Without it, the cells in your body cannot absorb glucose from the blood to use as energy. Millions of people around the world either do not produce enough insulin, cannot use it properly, or both. Understanding what insulin does, and what happens when it does not work the way it should, is the first step toward better metabolic health, smarter diabetes management, and a longer life.
This guide covers everything you need to know: what insulin is, how it works at the cellular level, the difference between type 1 and type 2 diabetes, how to lower insulin resistance naturally, the latest medications including GLP-1 receptor agonists, and the most advanced insulin delivery devices available today.
Key Takeaways
- Insulin is a vital hormone that allows cells to absorb glucose from the bloodstream. Without it, blood sugar builds up and causes serious damage over time.
- Fasting insulin is an early and sensitive marker of metabolic health, often catching problems before fasting glucose does.
- Insulin resistance is a widespread and reversible condition driven by inflammation, excess body fat, poor diet, and inactivity, and it can often be improved through lifestyle changes.
- Type 1 diabetes is an autoimmune disease requiring lifelong insulin therapy; type 2 diabetes is a metabolic disorder often manageable with lifestyle changes, oral medications, and injectable therapies like GLP-1 receptor agonists.
- GLP-1 receptor agonists are transformative medications that work alongside insulin to regulate blood sugar, support weight loss, and protect the heart.
- Long-acting basal insulins (Lantus, Tresiba, Levemir) and rapid-acting bolus insulins (Admelog, Fiasp, Lyumjev) each serve specific roles in a complete insulin regimen.
- Insulin delivery technology has advanced dramatically, with closed-loop AID systems like the iLet, Omnipod 5, MiniMed 780G, and twiist offering near-automated blood sugar management.
- Always work closely with your healthcare team when making changes to insulin therapy or delivery devices.
What Is Insulin and What Does It Do?
Insulin is a polypeptide hormone made by the beta cells inside the pancreas. To picture how it works, think of insulin as a key. Glucose, the sugar in your blood that comes from the food you eat, cannot enter most of your body’s cells on its own. Insulin is the key that unlocks the door, allowing glucose to move from your bloodstream into your cells where it is burned for energy.
When you eat a meal, your blood sugar rises. Your pancreas senses this rise and releases insulin in response. The insulin travels through the blood, signals cells to open up and absorb glucose, and blood sugar comes back down to a healthy level. This is the normal cycle of glucose regulation.
Without enough insulin or when the body cannot use insulin properly glucose builds up in the blood. Over time, this state of high blood sugar, called hyperglycemia, damages blood vessels, nerves, kidneys, eyes, and the heart. This is why managing insulin and blood glucose levels is so critical for long-term health.
How Insulin Works at the Cellular Level?
When insulin attaches to a receptor on the surface of a cell, it triggers a chain reaction inside the cell. This chain reaction activates proteins that allow glucose transport channels called GLUT4 transporters to move to the surface of the cell. Once on the surface, these channels act like doorways that let glucose flow in from the bloodstream.
The liver plays a special role in this process. After a meal, the liver absorbs a large portion of the incoming glucose from the blood and stores it as glycogen. This is like storing extra fuel in a warehouse. Insulin signals the liver to take in and store glucose rather than release it.
Muscles also rely heavily on insulin. During exercise, muscles can absorb some glucose without insulin one of the reasons physical activity is so helpful for people with insulin resistance. But at rest, muscle cells need insulin to efficiently take in glucose.
Adipose tissue (body fat) also responds to insulin. Insulin signals fat cells to store fat and prevents fat from being broken down. This is why high insulin levels over a long period of time a common sign of insulin resistance can contribute to weight gain.
What Is Fasting Insulin and Why Does It Matter?
A fasting insulin test measures how much insulin your pancreas is producing when you have not eaten for at least 8 hours. This test gives doctors a snapshot of your baseline insulin output and can reveal important clues about your metabolic health.
Normal fasting insulin levels are generally between 2 and 20 microunits per milliliter (mcIU/mL), though many integrative medicine practitioners prefer to see levels below 10 mcIU/mL for optimal metabolic health. When fasting insulin is chronically elevated, it often points to insulin resistance a condition where the body’s cells are not responding properly to insulin.
Why does fasting insulin matter? Because it can serve as an early warning signal. Many people develop elevated fasting insulin years before their blood glucose levels rise to diabetic range. This means fasting insulin can help identify metabolic dysfunction long before a diagnosis of type 2 diabetes is made.
If your doctor has never ordered a fasting insulin test, it is worth asking about. Catching elevated insulin early gives you the best window to make lifestyle changes that can reverse the problem before it progresses.
Understanding Insulin Resistance
Insulin resistance is a condition in which the cells of the body particularly in the liver, muscles, and fat tissue do not respond efficiently to insulin’s signals. Think of it like a lock that has become sticky. The key (insulin) is there, but it takes much more effort and many more keys to open the door.
In response, the pancreas produces more and more insulin to overcome the resistance. For a while, this works: blood sugar stays in a normal range because the pancreas is compensating. But over time, the pancreas can burn out. Insulin output starts to fall, blood sugar climbs, and type 2 diabetes begins to develop.
What Causes Insulin Resistance?
Research published in 2025 confirms that insulin resistance is not one simple problem it is a complex condition driven by several overlapping factors:
- Excess body fat, especially visceral fat stored around the abdomen
- Chronic low-grade inflammation, driven by fat cells releasing inflammatory cytokines
- Mitochondrial dysfunction, which impairs how cells process glucose and fatty acids
- Disrupted lipid metabolism, where abnormal fat buildup in muscles and liver interferes with insulin signaling
- Poor sleep and chronic stress, both of which raise cortisol and disrupt glucose regulation
- Sedentary lifestyle, which reduces the muscles’ ability to absorb glucose
Recent research has also highlighted sex-specific differences in insulin sensitivity. Men and women appear to develop insulin resistance through somewhat different biological pathways, and they may respond differently to treatment. This is an active area of research, with scientists working to develop more personalized treatment approaches based on sex, genetics, and metabolic profile.
Conditions Linked to Insulin Resistance
Insulin resistance rarely travels alone. It is strongly associated with a cluster of metabolic problems known as metabolic syndrome, which includes:
- High blood pressure (hypertension)
- Abnormal cholesterol and triglyceride levels
- Excess abdominal fat
- Elevated fasting blood glucose
This cluster dramatically raises the risk of cardiovascular disease, stroke, and type 2 diabetes. Emerging research in 2025 has also linked insulin resistance to Parkinson’s disease and poor recovery outcomes after stroke, suggesting its damage reaches far beyond just blood sugar.
How to Lower Insulin Resistance Naturally?
The good news about insulin resistance is that it can often be reversed or at least significantly improved through lifestyle changes. You do not always need medication to start making a real difference.
Regular Physical Activity
Exercise is one of the most powerful tools for improving insulin sensitivity. When you move your muscles, they can absorb glucose directly from the blood without needing insulin. This effect lasts for hours after exercise.
Both aerobic exercise (walking, cycling, swimming, jogging) and resistance training (weightlifting, bodyweight exercises) improve insulin sensitivity, but research suggests that combining both types gives the best results. Even breaking up long periods of sitting with short walks has been shown to help.
Aim for at least 150 minutes of moderate-intensity aerobic activity per week, plus two to three days of resistance training. For people who are new to exercise, starting small and gradually increasing is the safest and most sustainable approach.
A Whole-Food, Low-Glycemic Diet
What you eat has a massive impact on insulin levels and insulin sensitivity. Foods that cause rapid spikes in blood sugar white bread, sugary drinks, processed snacks trigger large surges of insulin. Over time, repeated insulin spikes contribute to insulin resistance.
A diet focused on whole, minimally processed foods helps keep blood sugar and insulin levels more stable. Key dietary principles include:
- Prioritizing non-starchy vegetables, legumes, and whole grains over refined carbohydrates
- Including healthy fats from sources like olive oil, avocado, and nuts
- Choosing lean proteins like fish, poultry, eggs, and plant-based sources
- Limiting added sugars, sweetened beverages, and ultra-processed foods
Some people also benefit from time-restricted eating (eating within a set window of hours), which may help reduce insulin levels during fasting periods. Recent research on ketosis suggests that low-carbohydrate and ketogenic diets can also meaningfully improve insulin sensitivity in some individuals.
Weight Loss
Losing even 5 to 10 percent of body weight can significantly improve insulin sensitivity. This is because excess body fat particularly visceral fat around the organs is a major driver of insulin resistance and inflammation. As fat is lost, the inflammatory signaling that interferes with insulin receptors decreases, and cells start responding to insulin more effectively.
Sleep and Stress Reduction
Poor sleep and chronic stress are underrated contributors to insulin resistance. Cortisol, the stress hormone, directly raises blood glucose and blunts insulin sensitivity. Getting 7 to 9 hours of quality sleep per night and managing stress through activities like meditation, yoga, deep breathing, or social connection are all legitimate strategies for improving insulin function.
Type 1 vs. Type 2 Diabetes: The Key Differences
Understanding the type 1 vs. type 2 diabetes distinction is essential for understanding insulin therapy.
Type 1 Diabetes
Type 1 diabetes is an autoimmune disease. The body’s immune system mistakenly attacks and destroys the beta cells in the pancreas the cells that produce insulin. Once these cells are destroyed, the pancreas produces little to no insulin at all.
People with type 1 diabetes must take insulin every day for the rest of their lives. Without it, blood sugar rises to dangerous levels, and a life-threatening condition called diabetic ketoacidosis (DKA) can develop. Type 1 typically develops in childhood or early adulthood, though it can appear at any age.
Type 1 diabetes affects approximately 8 to 10 percent of all people with diabetes. It is not caused by diet or lifestyle.
Type 2 Diabetes
Type 2 diabetes is a metabolic condition. The body either does not produce enough insulin or cannot use it properly due to insulin resistance. Blood sugar rises because cells are not absorbing glucose effectively.
Type 2 is far more common than type 1, accounting for about 90 to 95 percent of all diabetes cases. It is strongly linked to lifestyle factors excess body weight, physical inactivity, poor diet as well as genetics and family history.
Unlike type 1, type 2 can often be managed and in some cases put into remission through lifestyle changes, oral medications, and newer injectable medications. However, many people with long-standing type 2 diabetes eventually need insulin therapy as the pancreas loses its ability to compensate.
The Relationship Between Type 2 Diabetes and Insulin
To understand the relationship between type 2 diabetes and insulin, it helps to think of it as a communication breakdown between a key and a lock.
In a healthy body, insulin is the key that opens the doors to your cells so glucose (sugar) can enter and be used for energy. In type 2 diabetes, that system stops working properly.
Here is exactly how they are connected, broken down step-by-step:
1. The Normal Routine (The “Key” Works)
When you eat, your body breaks food down into glucose, which enters your bloodstream. Sensing this rise in sugar, your pancreas releases insulin. Insulin attaches to your cells, signals them to open up, and absorbs the glucose. Your blood sugar drops back to normal, and your cells get fed.
2. Insulin Resistance (The “Lock” is Jammed)
In type 2 diabetes, the main issue is insulin resistance. Your pancreas is still making insulin, but your cells’ receptors (the locks) have become stubborn or “deaf” to it. Because the cells aren’t opening up, glucose gets trapped in your bloodstream, causing your blood sugar levels to spike.
3. Pancreatic Overdrive (The Compensation Phase)
The pancreas notices that blood sugar is still high and thinks, “Oh, I must not have sent enough keys!”
- It goes into overdrive, pumping out more and more insulin to force the glucose into the cells.
- For a while, this works. But over time, having chronically high levels of insulin (hyperinsulinemia) can cause other health complications, like weight gain and increased blood pressure.
4. Pancreatic Burnout (The Progression)
Eventually, the pancreas can’t keep up with the constant demand. The beta cells (the ones that make insulin) get exhausted and can stop working correctly or even die off.
- At this stage, a person with type 2 diabetes has a double whammy: their cells are resistant to insulin, AND their body is no longer making enough of it.
- This is why many people with long-term type 2 diabetes eventually need to inject insulin, even though their body used to make plenty of it.
In short: Type 1 diabetes is a shortage of insulin (an autoimmune issue). Type 2 diabetes is a problem with insulin efficiency (resistance) that can eventually lead to a shortage later on.
Gestational Diabetes
A third form, gestational diabetes, develops during pregnancy when hormonal changes make the body more resistant to insulin. It typically resolves after delivery, but it raises the mother’s risk of developing type 2 diabetes later in life.
The Powerful Role of GLP-1 and Insulin Together
Glucagon-like peptide-1 (GLP-1) is an incretin hormone produced in the L-cells of the small intestine after meals. It plays a central role in blood sugar regulation by working alongside insulin through several mechanisms:
- It stimulates insulin release from the pancreas, but only when blood glucose is elevated meaning it does not cause dangerous low blood sugar on its own
- It suppresses glucagon, the hormone that tells the liver to release stored glucose into the bloodstream
- It slows gastric emptying, meaning food moves more slowly from the stomach to the intestine, leading to a more gradual rise in blood sugar after meals
- It reduces appetite by acting on the brain, which can help with weight management
In recent years, drugs that mimic GLP-1 called GLP-1 receptor agonists (GLP-1 RAs) have become one of the most exciting and widely used medication classes in diabetes and obesity medicine. These include well-known drugs like semaglutide (Ozempic, Wegovy), liraglutide (Victoza, Saxenda), and dulaglutide (Trulicity).
A 2025 review published in PMC describes how GLP-1 RAs have demonstrated extraordinary results: reducing HbA1c (a measure of average blood sugar over three months) by 1.5 to 2.0 percent, promoting weight loss of 7 to 24 percent depending on the drug and dose, and providing 14 to 20 percent reductions in major cardiovascular events.
The newest class of drugs, called dual GIP/GLP-1 receptor agonists, targets both GLP-1 and a related incretin hormone called glucose-dependent insulinotropic polypeptide (GIP). Tirzepatide (Mounjaro, Zepbound) is the leading drug in this class. Clinical trials have shown weight loss of up to 22 to 24 percent a magnitude previously only achievable with bariatric surgery.
The American Diabetes Association (ADA) issued a statement in January 2025 acknowledging the dramatic rise in use of these medications and raising concerns about compounded versions being sold outside of regulated pharmacy channels. The ADA urged patients to only use FDA-approved formulations from licensed pharmacies.
Managing Diabetes: From Lifestyle to Medication
Diabetes management is not one-size-fits-all. The right approach depends on what type of diabetes you have, how long you have had it, your current blood sugar levels, and your overall health goals.
Type 1 Diabetes Management
People with type 1 diabetes must replace the insulin their pancreas cannot make. This usually involves:
- Basal insulin: a long-acting insulin taken once or twice daily to keep blood sugar stable between meals and overnight
- Bolus insulin: a rapid-acting insulin taken before meals to cover the rise in blood sugar from eating
- Continuous Glucose Monitoring (CGM): a small sensor worn on the skin that tracks blood sugar in real time
- Insulin pumps: devices that deliver insulin continuously throughout the day, often integrated with CGMs
Type 2 Diabetes Management
The first step in managing type 2 diabetes is typically lifestyle modification improving diet, increasing physical activity, and losing weight if needed. When lifestyle changes are not enough, medications are added.
Common medication classes for type 2 diabetes include:
- Metformin: the most widely used first-line oral medication, which lowers glucose production in the liver
- SGLT2 inhibitors (like empagliflozin and dapagliflozin): cause the kidneys to excrete excess glucose in urine; also have heart and kidney protective benefits
- DPP-4 inhibitors: mildly lower blood sugar by prolonging the action of naturally occurring GLP-1
- GLP-1 receptor agonists: injectable medications that powerfully lower blood sugar, reduce appetite, promote weight loss, and protect the cardiovascular system
- Insulin: used when other medications are not sufficient to control blood sugar
Many people with type 2 diabetes can achieve excellent blood sugar control and even put the disease into remission with the right combination of treatment. Working closely with an endocrinologist or diabetes care team makes a major difference in outcomes.
Long-Acting Insulin: Names, Types, and Uses
Long-acting insulin, also called basal insulin, is designed to provide a slow, steady release of insulin throughout the day and night. It replaces the background insulin that the pancreas normally produces between meals.
Common Long-Acting Insulin Names
- Lantus (insulin glargine): One of the most widely used basal insulins. It provides consistent coverage for up to 24 hours with little to no peak, reducing the risk of nighttime hypoglycemia.
- Levemir (insulin detemir): A basal insulin that works for 12 to 24 hours, sometimes taken twice daily. It binds to albumin in the blood, which helps extend its action.
- Tresiba (insulin degludec): The longest-acting basal insulin currently available, with a half-life that extends beyond 42 hours. It provides very stable, flat coverage and carries a low risk of hypoglycemia. Its ultra-long action means that missing a dose has less immediate impact than with shorter-acting insulins.
- Toujeo (insulin glargine U-300): A higher concentration version of insulin glargine that delivers a more consistent flat profile and is injected in a smaller volume.
- Basaglar (insulin glargine): A biosimilar (a near-copy) of Lantus, offering similar action at a potentially lower cost.
Choosing the right basal insulin depends on individual factors including lifestyle, blood sugar patterns, hypoglycemia risk, and cost. An endocrinologist can help determine which option is best for each person.
Rapid-Acting Insulin: Admelog and Beyond
While basal insulin handles background glucose control, rapid-acting insulins (also called mealtime or bolus insulins) are designed to work quickly to cover the rise in blood sugar after eating.
What Is Admelog?
Admelog (insulin lispro) is a rapid-acting insulin analog used to improve blood sugar control in adults and children with diabetes. It is a biosimilar version of Humalog (also insulin lispro). Admelog starts working within 15 minutes of injection, reaches its peak effect between 30 and 90 minutes, and lasts for 3 to 5 hours. It is typically injected within 15 minutes before or immediately after starting a meal.
Other Rapid-Acting Insulins
- Humalog (insulin lispro): One of the most established rapid-acting insulins
- NovoLog (insulin aspart): Widely used for mealtime coverage
- Apidra (insulin glulisine): Another rapid-acting option with a slightly different action profile
- Fiasp (faster-acting insulin aspart): An ultra-rapid insulin that starts working in as little as 5 minutes particularly useful in closed-loop insulin delivery systems and for people who need faster postmeal coverage
- Lyumjev (ultra-rapid lispro): Similar to Fiasp in speed, Lyumjev also begins working very rapidly and is showing strong results especially in children and adolescents using advanced insulin pump systems
Recent studies with the Medtronic MiniMed 780G pump found that both Fiasp and Lyumjev improved postprandial blood sugar control in children and young people compared to standard rapid-acting insulins, making them particularly promising choices for closed-loop systems.
Insulin-Like Growth Factor 1 (IGF-1): What It Is and How It Differs
Insulin-like growth factor 1 (IGF-1) is a hormone that is structurally similar to insulin, but plays a very different role in the body. While insulin regulates blood sugar, IGF-1 primarily drives cellular growth and development.
IGF-1 is produced mainly in the liver in response to growth hormone signals from the pituitary gland. It acts throughout the body to stimulate the growth of bones, muscles, and organs during childhood and adolescence, and continues to play a maintenance role in adults.
Because IGF-1 and insulin share similar molecular structures, IGF-1 can bind weakly to insulin receptors, and insulin can bind weakly to IGF-1 receptors. This overlap in signaling is the subject of significant research particularly regarding cancer biology, aging, and metabolic diseases.
Abnormally high IGF-1 levels (a condition called acromegaly, caused by a pituitary tumor) can worsen insulin resistance and cause type 2 diabetes-like blood sugar problems. Conversely, very low IGF-1 levels are associated with growth disorders. Testing IGF-1 is standard when growth hormone disorders are suspected.
Insulin Delivery Devices: Pumps, Pens, and Syringes
There are several ways to deliver insulin into the body. Each method has pros and cons depending on lifestyle, comfort, and individual needs.
Insulin Pens
An insulin pen is a handheld device that looks like a large writing pen. It holds an insulin cartridge and uses a disposable needle to inject insulin. Pens come in two main types:
- Prefilled pens: Come ready to use with a fixed cartridge of insulin and are discarded when empty
- Reusable pens: Accept replaceable insulin cartridges and use a new needle for each injection
Insulin pens are popular because they are portable, easy to use, allow precise dosing in half-unit or full-unit increments, and require less handling than drawing insulin from a vial with a syringe. The InPen (by Medtronic) is a smart insulin pen that connects to a smartphone app to track doses, timing, and remaining insulin on board, helping people avoid stacking doses accidentally.
Insulin Syringes
An insulin syringe draws insulin from a vial and delivers it by injection. Standard U-100 syringes like BD U-100 insulin syringes are one of the most widely used tools worldwide. They are low-cost and reliable, and many patients who have used them for years prefer their familiarity.
When using a syringe, the correct technique matters: injecting into the correct tissue (subcutaneous, meaning just under the skin), rotating injection sites to prevent lipohypertrophy (hard lumps that form when the same spot is used too often), and using a new needle every time to minimize discomfort and infection risk.
Insulin Needles
Insulin needles come in different lengths and gauges (widths). Shorter, finer needles such as 4mm, 31-gauge needles are now recommended for most people regardless of body size, as research has consistently shown they deliver insulin into the correct subcutaneous layer while being more comfortable than longer needles. Your healthcare provider or diabetes educator can help you choose the best needle size.
The Latest in Insulin Pump Technology for 2025 and 2026
Insulin pump technology has undergone a dramatic transformation over the past decade. The modern era of Automated Insulin Delivery (AID), also called closed-loop systems or artificial pancreas technology, combines an insulin pump, a continuous glucose monitor, and a smart algorithm to automatically adjust insulin delivery in real time.
How Closed-Loop Systems Work
In a closed-loop AID system:
- A CGM worn on the skin continuously measures glucose levels every few minutes
- The glucose data is sent wirelessly to a control algorithm (often running on a smartphone or the pump itself)
- The algorithm predicts where blood sugar is headed and tells the insulin pump to increase, decrease, or pause insulin delivery accordingly
This is called a closed loop because the feedback from the CGM “closes the loop” back to the pump no manual adjustments are needed for routine changes.
Leading AID Systems in 2025–2026
Medtronic MiniMed 780G One of the most advanced hybrid closed-loop systems currently available. It uses the SmartGuard Advance algorithm, which allows optional meal boluses. In September 2025, Medtronic received U.S. clearance to expand the 780G system to people with type 2 diabetes a significant milestone previously limited to type 1. It is now also CE-approved for children aged 2 and older and for use during pregnancy.
Omnipod 5 A tubeless patch pump (no tubes connecting the pump to the insertion site) that integrates with Dexcom G6, G7, and FreeStyle Libre 2 Plus CGMs. It uses SmartAdjust technology and is highly popular for its discreet, flexible design.
Tandem t:slim X2 and Tandem Mobi These pumps feature Control-IQ technology, which predicts glucose trends using Dexcom data and proactively adjusts insulin delivery. The Tandem Mobi is particularly compact.
iLet Bionic Pancreas (Beta Bionics) A fully closed-loop system that removes the burden of carbohydrate counting. Users simply enter their body weight during setup, and the system’s algorithm autonomously figures out the right dose. The iLet works with Dexcom G6, G7, and Abbott’s Libre 3 Plus in supported configurations. This system represents a major step toward a true “artificial pancreas.”
twiist AID System (Sequel Med Tech) A newer entrant launched in July 2025, combining the Tidepool Loop algorithm (“twiist Loop”) with the twiist pump and FreeStyle Libre 3 Plus sensor. It can be controlled from an iPhone and Apple Watch. Its iiSure technology detects disrupted insulin flow up to 9 times faster than other pumps. Early real-world data from 36 adult users showed an average Time in Range (TIR) of 80 percent well above the clinical target of 70 percent.
Twist Insulin Pump Another emerging device in the innovation pipeline, the Twist pump is designed with user comfort and integration as core priorities, representing the continuing push to make insulin delivery less burdensome for people who depend on it every day.
The Artificial Intelligence Revolution in Diabetes Care
Research published in 2025 and early 2026 highlights the growing role of artificial intelligence (AI) in closed-loop systems. AI-driven algorithms including neural network-based approaches, are being developed to better predict individual glucose patterns, adapt to exercise, stress, illness, and changes in diet, and further minimize both high and low blood sugar events.
A dual closed-loop system called DuoLoop, reported in Advanced Materials in January 2026, integrates Bluetooth-connected CGM prediction with a PID learning algorithm for fully autonomous insulin delivery, showing reduced glucose fluctuations compared to existing single-loop systems.
Continuous Glucose Monitors: The Foundation of Modern Diabetes Tech
A Continuous Glucose Monitor (CGM) is a small sensor inserted just under the skin, typically on the arm or abdomen, that measures glucose levels in the interstitial fluid every 1 to 5 minutes. It wirelessly transmits readings to a receiver, smartphone, smartwatch, or insulin pump.
Leading CGM systems in 2025–2026 include:
- Dexcom G7: Slim, highly accurate, with a 10-day wear period
- Abbott FreeStyle Libre 3 Plus: Known for small size and long wear time
- Medtronic Simplera Sync: Designed for use with the MiniMed 780G
- Eversense 365: An implantable CGM that lasts 365 days, reducing the burden of frequent sensor replacements
CGMs give people with diabetes information they could never get from occasional finger-stick readings. They show not just the current glucose level but the direction and speed of change, critical for making good decisions about food, exercise, and insulin dosing.
Importantly, despite the availability of CGMs and AID systems, adoption remains low. A 2025 study published in JAMA Network Open found that in the period from 2021 to 2023, only 47 percent of children and 22 percent of adults with type 1 diabetes in the United States were using a CGM together with an insulin pump. Access, cost, and clinician knowledge gaps are major barriers.
Choosing the Right Insulin Needles and Injection Technique
The quality and comfort of insulin injections depend significantly on needle choice and injection technique. Here are the key considerations:
Needle Length
Shorter needles (4mm) are recommended for most people across body sizes because insulin needs to be injected into the subcutaneous fat layer, not into muscle. Studies have found that even people with higher body weights can use 4mm needles without compromising insulin absorption.
Needle Gauge
Gauge refers to the thickness of the needle. Higher gauge numbers mean thinner needles. Common gauges for insulin injection are 30G to 32G. Thinner needles cause less discomfort, making adherence to injection regimens easier.
Injection Site Rotation
It is essential to rotate injection sites within the recommended areas (abdomen, outer thighs, upper arms, buttocks). Repeatedly injecting into the same spot causes a buildup of scar tissue called lipohypertrophy, which can impair insulin absorption and lead to unpredictable blood sugar levels.
Safe Needle Disposal
Used needles should always be placed in an approved sharps container and never in regular household trash. Many pharmacies and medical facilities offer sharps disposal services.
When to See a Doctor or Endocrinologist
Insulin management and diabetes care are highly individual. What works well for one person may not be right for another. Regular professional guidance is essential.
You should consult a doctor or endocrinologist (a specialist in hormone and metabolic disorders) if:
- You have been diagnosed with type 1 or type 2 diabetes
- You are struggling to reach your blood sugar goals despite current treatment
- You are considering switching to an insulin pump or CGM
- You are pregnant or planning to become pregnant and have diabetes
- You have signs of insulin resistance or metabolic syndrome
- You want to start new medications or adjust your current regimen
- You are experiencing frequent low blood sugar events (hypoglycemia)
Diabetes management is a team effort. Working with an endocrinologist, a registered dietitian, and a certified diabetes care and education specialist (CDCES) provides the best outcomes.
Frequently Asked Questions (FAQ)
What is the difference between basal and bolus insulin?
Basal insulin is long-acting and provides background insulin coverage throughout the day and night. Bolus insulin is rapid-acting and covers the rise in blood sugar that occurs after meals.
Can insulin resistance be reversed?
In many cases, yes. Regular exercise, a healthy whole-food diet, weight loss, and improved sleep can significantly reduce or reverse insulin resistance, especially when addressed early.
What are normal fasting insulin levels?
Most labs consider fasting insulin under 20 mcIU/mL as normal, but optimal metabolic health is often associated with levels below 10 mcIU/mL.
What is IGF-1 and how is it different from insulin?
IGF-1 (insulin-like growth factor 1) is a growth hormone that promotes cell growth and development. While it is structurally similar to insulin, it primarily drives growth rather than blood sugar regulation.
What is the best insulin pump available in 2026?
The “best” pump depends on individual needs. The iLet Bionic Pancreas offers the most automation (no carb counting required). The Omnipod 5 is popular for its tubeless design. The MiniMed 780G is well-established and now approved for type 2 diabetes.
Is Admelog the same as Humalog?
Admelog is a biosimilar of Humalog (both are insulin lispro). They work in essentially the same way but are manufactured by different companies. Admelog may be available at a lower cost.
Leave a Reply